156 related articles for article (PubMed ID: 12830415)
1. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.
Korenromp EL; Scano F; Williams BG; Dye C; Nunn P
Clin Infect Dis; 2003 Jul; 37(1):101-12. PubMed ID: 12830415
[TBL] [Abstract][Full Text] [Related]
2. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
5. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City.
Driver CR; Munsiff SS; Li J; Kundamal N; Osahan SS
Clin Infect Dis; 2001 Nov; 33(10):1762-9. PubMed ID: 11595988
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
[TBL] [Abstract][Full Text] [Related]
8. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
[TBL] [Abstract][Full Text] [Related]
9. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
11. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
[TBL] [Abstract][Full Text] [Related]
12. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
Harries AD; Hargreaves NJ; Salaniponi FM
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
[TBL] [Abstract][Full Text] [Related]
13. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
[TBL] [Abstract][Full Text] [Related]
14. Hypoadrenalism is not associated with early mortality during tuberculosis treatment in Malawi.
Beadsworth MB; van Oosterhout JJ; Diver MJ; Faragher EB; Shenkin A; Mwandumba HC; Khoo S; O'Dempsey T; Squire SB; Zijlstra EE
Int J Tuberc Lung Dis; 2008 Mar; 12(3):314-8. PubMed ID: 18284838
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
16. Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients.
Lopez-Cortes LF; Marin-Niebla A; Lopez-Cortes LE; Villanego I; Rodriguez-Diez M; Pascual-Carrasco R
Int J Tuberc Lung Dis; 2005 Dec; 9(12):1385-90. PubMed ID: 16466062
[TBL] [Abstract][Full Text] [Related]
17. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
[TBL] [Abstract][Full Text] [Related]
18. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Stout JE
Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
[TBL] [Abstract][Full Text] [Related]
19. Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB.
Corbett EL; Charalambous S; Fielding K; Clayton T; Hayes RJ; De Cock KM; Churchyard GJ
J Infect Dis; 2003 Oct; 188(8):1156-63. PubMed ID: 14551886
[TBL] [Abstract][Full Text] [Related]
20. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
Erokhin VV; Kornilova ZKh; Alekseeva LP
Probl Tuberk Bolezn Legk; 2005; (10):20-8. PubMed ID: 16318255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]